US Patent Issued to Leukocare on July 8 for "Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy" (German Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,375, issued on July 8, was assigned to Leukocare AG (Martinsried, Germany).

"Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy" was invented by Kristina Kemter (Garching bei Munchen, Germany) and Martin Scholz (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for preparing viral vector-based compositions wherein the viral vector-based particles present in the composition have a particle size distribution with a polydispersity index (PDI) of less than 0.5, the method comprising the steps: (a) providing replication-deficient viral vectors; (b) providing a soluti...